Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cue Biopharma (CUE)
:CUE
See the Price Targets and Ratings of:
CUE Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JMP Securities
$2
Buy
45.99%
Upside
Reiterated
11/18/24
Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)
Stifel Nicolaus
$4
Buy
191.97%
Upside
Reiterated
11/15/24
Stifel Nicolaus Remains a Buy on Cue Biopharma (CUE)
Oppenheimer
$6
Buy
337.96%
Upside
Reiterated
08/20/24
Oppenheimer Reaffirms Their Buy Rating on Cue Biopharma (CUE)
Piper Sandler
$3
Buy
118.98%
Upside
Reiterated
08/20/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (NYSE: PRGO), Cue Biopharma (NASDAQ: CUE) and United Therapeutics (NASDAQ: UTHR)
Jefferies
$6
Buy
337.96%
Upside
Initiated
03/13/24
Analysts' Top Healthcare Picks: Cooper Co (COO), Regeneron (REGN)
Best Analysts Covering Cue Biopharma
Which Analyst Should I Follow If I Want to Buy CUE and Sell After:
1 Month
xxx
Success Rate
7/14 ratings generated profit
Average Return
-3.46%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -3.46% per trade.
3 Months
xxx
Success Rate
7/14 ratings generated profit
Average Return
+1.35%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.35% per trade.
1 Year
Success Rate
5/14 ratings generated profit
Average Return
-18.19%
reiterated a buy rating 3 months ago
Copying Stephen Willey's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of -18.19% per trade.
2 Years
xxx
Success Rate
3/14 ratings generated profit
Average Return
-42.36%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 21.43% of your transactions generating a profit, with an average return of -42.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CUE Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Nov 24
Strong Buy
8
8
6
8
9
Buy
0
0
0
0
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
8
6
8
10
Each month's total comprises the sum of three months' worth of ratings.
CUE Stock Forecast FAQ
What is CUE’s average 12-month price target, according to analysts?
Based on analyst ratings, Cue Biopharma’s 12-month average price target is $2.00.
What is CUE’s upside potential, based on the analysts’ average price target?
Cue Biopharma has 45.99% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CUE a Buy, Sell or Hold?
Cue Biopharma has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cue Biopharma’s price target?
The average price target for Cue Biopharma is $2.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 45.99% Increase from the current price of $1.37.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 45.99% Increase from the current price of $1.37.
What do analysts say about Cue Biopharma?
Cue Biopharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of CUE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.